» Articles » PMID: 34979155

TSPAN1, a Novel Tetraspanin Member Highly Involved in Carcinogenesis and Chemoresistance

Overview
Publisher Elsevier
Date 2022 Jan 3
PMID 34979155
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The tetraspanin (TSPAN) family constitutes a poorly explored family of membrane receptors involved in various physiological processes, with relevant roles in anchoring multiple proteins, acting as scaffolding proteins, and cell signaling. Recent studies have increasingly demonstrated the involvement of TSPANs in cancer. In particular, tetraspanin 1 (also known as TSPAN1, NET-1, TM4C, C4.8 or GEF) has been implicated in cell survival, proliferation and invasion. Recently, our laboratory revealed a key role of TSPAN1 in the acquired resistance of tumor cells to conventional chemotherapy (e.g., cisplatin). In this review, we summarize and discuss the latest research on the physiological mechanisms of TSPANs in cancer and, in particular, on TSPAN1 regulating resistance to chemotherapy. A model of TSPAN1 action is proposed, and the potential of targeting TSPAN1 in anticancer therapeutic strategies is discussed.

Citing Articles

Integrating traditional machine learning with qPCR validation to identify solid drug targets in pancreatic cancer: a 5-gene signature study.

Wang X, Yu P, Jia W, Wan B, Ling Z, Tang Y Front Pharmacol. 2025; 15():1539120.

PMID: 39850570 PMC: 11754184. DOI: 10.3389/fphar.2024.1539120.


Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications.

Lin Z, Li G, Jiang K, Li Z, Liu T Mol Cancer. 2024; 23(1):191.

PMID: 39244548 PMC: 11380334. DOI: 10.1186/s12943-024-02106-8.


Tetraspanins in digestive‑system cancers: Expression, function and therapeutic potential (Review).

Chen K, Li Q, Li Y, Jiang D, Chen L, Jiang J Mol Med Rep. 2024; 30(5).

PMID: 39239742 PMC: 11411235. DOI: 10.3892/mmr.2024.13324.


Unveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysis.

Lu B, Liu Y, Yao Y, Zhu D, Zhang X, Dong K Biol Direct. 2024; 19(1):72.

PMID: 39175035 PMC: 11340126. DOI: 10.1186/s13062-024-00516-8.


Unveiling the Potential of Migrasomes: A Machine-Learning-Driven Signature for Diagnosing Acute Myocardial Infarction.

Zhu Y, Chen Y, Xu J, Zu Y Biomedicines. 2024; 12(7).

PMID: 39062199 PMC: 11274667. DOI: 10.3390/biomedicines12071626.